Cardiovascular instability requiring treatment after intravenous heparin for cardiopulmonary bypass.
Jacka
M J
MJ
Department of Anesthesia, Dalhousie University, Atlantic Health Sciences Corporation, Saint John, New Brunswick, Canada. mjjacka@vianet.on.ca
Clark
A G
AG
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects*; D001794:Blood Pressure / Q000502:physiology; D002315:Cardiopulmonary Bypass; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D005260:Female; D006339:Heart Rate / Q000502:physiology; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007431:Intraoperative Complications / Q000139:chemically induced*; D008297:Male; D012189:Retrospective Studies
D000925:Anticoagulants; D006493:Heparin